| Name | 5-Methyl-4-(4-methylphenyl)-1,3-thiazol-2-amine |
|---|---|
| Synonyms | 5-methyl-4-p-tolyl-thiazol-2-ylamine |
| Density | 1.185g/cm3 |
|---|---|
| Boiling Point | 359.2ºC at 760mmHg |
| Molecular Formula | C11H12N2S |
| Molecular Weight | 204.29100 |
| Flash Point | 171ºC |
| Exact Mass | 204.07200 |
| PSA | 67.15000 |
| LogP | 3.59030 |
| Vapour Pressure | 2.42E-05mmHg at 25°C |
| Index of Refraction | 1.628 |
| HS Code | 2934100090 |
|---|
|
~96%
16942-66-8 |
| Literature: TAIVEX THERAPEUTICS CORPORATION; HUANG, Yu-Ling; CHUANG, Shih-Hsien; LEE, Ying-Shuan Eda; HUANG, Jiann-Jyh; LAU, Johnson Patent: WO2013/82324 A1, 2013 ; Location in patent: Paragraph 00266 ; |
|
~%
16942-66-8 |
| Literature: Indian Journal of Chemistry, Section B: Organic Chemistry Including Medicinal Chemistry, , vol. 15, p. 356 - 358 |
| Precursor 1 | |
|---|---|
| DownStream 0 | |
| HS Code | 2934100090 |
|---|---|
| Summary | 2934100090 other compounds containing an unfused thiazole ring (whether or not hydrogenated) in the structure VAT:17.0% Tax rebate rate:9.0% Supervision conditions:none MFN tariff:6.5% General tariff:20.0% |